Our findings identify MAMDC2 as a stromal-associated effector of EMT–stromal crosstalk in MSS colorectal cancer with a high TSR, demonstrating its high expression in tumors with a high TSR and peritoneal metastases. Here, MAMDC2 is linked to colorectal cancer.